Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVO · against 557 other Healthcare companies listed in US-listed
Ranked #256 of 558 · scores higher than 53% of peers
Bars: peers in each 10-point band of the profitability score41 peers with a profitability score of 30–39, including EVO · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -6.6% | -7.0% | 50% | 33% | |
| Operating marginHigher is better · 479 reported | -7.1% | -2.4% | 46% | 33% | |
| Return on assetsHigher is better · 582 reported | -6.0% | -7.8% | 52% | 33% | |
| Return on equityHigher is better · 531 reported | -26.1% | -19.7% | 46% | Context only | |
| Gross marginHigher is better · 601 reported | 8.5% | 43.9% | 34% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 251 | 1.3B USD | 31 | 20 | |
| 251 | 21.7B USD | 31 | 32 | |
| 256 | 327M USD | 30 | 40 | |
| 256 | 2.8B USD | 30 | 33 | |
| 256 | 551M USD | 30 | 27 | |
| 256 | 207.7B USD | 30 | 18 | |
| 256 | 820M USD | 30 | 41 | |
| 256 | 354M USD | 30 | 41 | |
| 256 | 1.2B USD | 30 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score